Journal Article Summary
The article investigates the relationship between specific genetic variants (CYP2C19 loss-of-function alleles) and the use of certain medications (omeprazole or esomeprazole) in patients taking clopidogrel, a common antiplatelet drug. This topic is significant because understanding how these genetic factors and medications interact can help predict cardiovascular outcomes, such as heart attacks or strokes, in patients with acute coronary syndrome or chronic coronary disease. The study aims to clarify conflicting data regarding the impact of these factors on cardiovascular events, which is crucial for optimizing patient care.
The researchers followed a cohort of 1,972 patients for one year, collecting data on their medications, health outcomes, and genetic information. They found that 30.8% of the patients carried CYP2C19 loss-of-function alleles, and during the follow-up, 12.8% experienced ischemic vascular events. Notably, patients with these genetic variants had a higher incidence of cardiovascular events compared to those without the alleles. Additionally, the use of omeprazole or esomeprazole was associated with an increased risk of cardiovascular events, particularly in non-carriers of the CYP2C19 alleles, indicating a potential drug-gene interaction that affects treatment outcomes.
Despite its valuable insights, the study has limitations, including potential gaps in clinical information and the possibility that less severe bleeding events were not captured. Patients should be aware of these findings and discuss with their healthcare providers the implications of their genetic makeup and any medications they are taking, especially if they are prescribed clopidogrel alongside proton pump inhibitors. This conversation can help tailor treatment plans to minimize risks and improve cardiovascular health outcomes.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ramste Markus, Ritvos Markus, Häyrynen Sergei, Kiiski Johanna I., Niemi Mikko, Sinisalo Juha. CYP2C19 loss‐of‐function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel. Clinical and Translational Science 2023. DOI: 10.1111/cts.13608. PMID: 37551775. PMCID: PMC10582682.
Featured Pill Pals Product
Omeprazole 20 mg Capsules --- 30 Count --- Generic for Prilosec --- Xiromed Pharma
Omeprazole 20 mg Capsules — 30 Count — Generic for Prilosec — Xiromed Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
